A HUWE1 regulatory helix gates ASCL1 degradation through its C-terminal phospho-degron in small cell lung cancer
Genes & Development · 01.11.2026 · 40 (21-22) · 1926-1954
DOI: 10.1101/gad.353898.126 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes & Development, online erschienen am 10.09.2026. Verfasst von Keita Masuzawa und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02215, USA. Hauptthemen laut MEDLINE: Ubiquitin-Protein Ligases, Small Cell Lung Carcinoma, Basic Helix-Loop-Helix Proteins, Proteolysis. Die Arbeit nennt 55 Literaturangaben. Gefördert von: American Cancer Society, Novartis Drug Discovery and Translational Research Program, Uehara Memorial Foundation Research Fellowship.
Abstract (Originalsprache)
Lineage-defining transcription factors are key oncogenic drivers but remain difficult to target pharmacologically due to the absence of ligandable pockets. The molecular rules governing substrate recognition by large HECT ubiquitin ligases also remain incompletely understood, limiting efforts to exploit these enzymes for targeted protein degradation. Here we combine genome-wide CRISPR knockout screening with base editor tiling screens at amino acid resolution, both coupled to an endogenous knock-in reporter of the SCLC lineage oncogenic transcription factor ASCL1, to systematically interrogate the mechanisms governing its degradation. These complementary screens unbiasedly identify the HECT ubiquitin ligase HUWE1 as the dominant regulator of ASCL1 stability in small cell lung cancer (SCLC) and resolve a conserved C-terminal phospho-degron centered on Ser207 and terminal Trp/Phe residues that are required for HUWE1 docking and ubiquitin-mediated degradation. Unexpectedly, base editor screening further uncovers a previously unrecognized regulatory module within HUWE1: a short negatively charged helix that functions as an autoinhibitory gate controlling access of phospho-degron substrates to HUWE1. Charge-flipping mutations within this regulatory helix relieve autoinhibition and accelerate degradation of multiple HUWE1 phospho-degron substrates, including ASCL1 and the canonical HUWE1 substrate DDIT4. Stabilization of ASCL1 through degron disruption paradoxically impairs SCLC proliferation, revealing that dynamic proteasome-coupled turnover is required for transcription factor function. Together, these findings reveal molecular rules governing HUWE1 phospho-degron recognition and identify a regulatory gate controlling substrate engagement. They also illustrate a generalizable strategy for resolving degradation mechanisms of undruggable transcription factors in their endogenous cellular context.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02215, USA.
- Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115, USA.
- Department of Chemistry and Chemical Biology, Harvard University Cambridge Massachusetts 02138 USA.
- Bioinformatics and Machine Learning, Ladders to Cures Accelerator, Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts 02142, USA.
- Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA.
- Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, USA.
Förderung
- American Cancer Society
- Novartis Drug Discovery and Translational Research Program
- Uehara Memorial Foundation Research Fellowship
- Japan Society for the Promotion of Science
- National Cancer Institue
Zitieren
APA
Masuzawa, K., Dong, K. D., XiaoYang Hu, C., Peng, T., Myung, Y., Singh, S., Li, X., Wang, T., Jin, C., Paulo, J. A., Yang, K., Schmid, E. W., Booker, M. A., Li, Y., Hong, D., Lazo, S., Tolstorukov, M. Y., Doench, J. G., Duplaquet, L., …, & Oser, M. G. (2026). A HUWE1 regulatory helix gates ASCL1 degradation through its C-terminal phospho-degron in small cell lung cancer. Genes & Development, 40(21-22), 1926-1954. https://doi.org/10.1101/gad.353898.126
Vancouver
Masuzawa K, Dong KD, XiaoYang Hu C, Peng T, Myung Y, Singh S, et al. A HUWE1 regulatory helix gates ASCL1 degradation through its C-terminal phospho-degron in small cell lung cancer. Genes & Development. 2026;40(21-22):1926-1954. doi:10.1101/gad.353898.126
BibTeX
@article{Masuzawa2026,
author = {Masuzawa, Keita and Dong, Kevin D and XiaoYang Hu, Calvin and Peng, Ting and Myung, Yoochan and Singh, Shilpa and Li, Xinyue and Wang, Tianchu and Jin, Cyrus and Paulo, Joao A and Yang, Ka and Schmid, Ernst W and Booker, Matthew A and Li, Yixiang and Hong, Deli and Lazo, Suzan and Tolstorukov, Michael Y and Doench, John G and Duplaquet, Leslie and Donovan, Katherine A and Iqbal, Sumaiya and Fischer, Eric S and Liau, Brian B and Gygi, Steven P and Oser, Matthew G},
title = {A HUWE1 regulatory helix gates ASCL1 degradation through its C-terminal phospho-degron in small cell lung cancer},
journal = {Genes & Development},
year = {2026},
volume = {40},
number = {21-22},
pages = {1926--1954},
doi = {10.1101/gad.353898.126}
}
EUVIMED